Clozapine‐induced third‐degree atrioventricular block and respiratory failure
The Brown University Psychopharmacology Update · 2026-04 · 37 (4) · 2-2
DOI: 10.1002/pu.31426 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 14.03.2026. Verfasst von Y. W. Francis Lam. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
The atypical antipsychotic clozapine is highly effective for patients with treatment‐resistant schizophrenia. However, its well‐recognized side‐effect profile, including severe toxicity such as agranulocytosis, limits its use. Significant cardiopulmonary adverse effects also have been associated with clozapine.
Zitieren
APA
Lam, Y. W. F. (2026). Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update, 37(4), 2-2. https://doi.org/10.1002/pu.31426
Vancouver
Lam YWF. Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update. 2026;37(4):2-2. doi:10.1002/pu.31426
BibTeX
@article{Lam2026,
author = {Lam, Y. W. Francis},
title = {Clozapine‐induced third‐degree atrioventricular block and respiratory failure},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {4},
pages = {2--2},
doi = {10.1002/pu.31426}
}
EUVIMED